Clinical Trials Logo

Healthy Male clinical trials

View clinical trials related to Healthy Male.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06105255 Active, not recruiting - Healthy Male Clinical Trials

A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553

Start date: May 24, 2023
Phase: Phase 1
Study type: Interventional

This is a phase I study to evaluate drug-drug interactions (DDIs) of D-1553 as a perpetrator combined with midazolam (CYP3A4 substrate), caffeine (CYP1A2 substrate), rosuvastatin (OATP1B1/OATP1B3 substrate), furosemide (OAT1/OATP1B3 substrate), and digoxin (P-gp substrate) and to evaluate DDIs of D-1553 as a victim combined with itraconazole (inhibitor of CYP3A4 and P-gp) and omeprazole (proton-pump inhibitor) in healthy male subjects.